The principles of PK-tailored prophylaxis
Chehadeh, H.-E.; Reininger, A.-J. · Zeitschrift für Orthopädie und Unfallchirurgie · 2013 · Heft S 01 · S. S32-S35
Bibliografische Angaben
Zusammenfassung
SummaryWhile prophylaxis with factor VIII (FVIII) is considered the first choice therapy for patients with severe haemophilia A the optimal prophylaxis regimen is still under scientific debate. A recent study demonstrated efficacy and safety of a PK-tailored prophylaxis regimen with rFVIII (ADVATE) aimed to maintain FVIII trough levels of ≥1% (19). The annual bleed rate (ABR) could be significantly reduced compared to the previous on-demand treatment period (p < 0.0001) and bodily pain, a health-related quality of life dimension of the SF-36v1 questionnaire also significantly improved (p = 0.0007). Thus PKtailor…